Nine PAAD patient-derived xenograft (PDX) models were divided into BICC1 high and BICC1 low groups according to BICC1 expression levels (Fig. 7a, Supplementary Fig. 23). The gene discussed is BICC1; the disease is pancreatic adenocarcinoma.